NDAQ Q2 Earnings Beat Estimates on Index and FinTech Growth

Nasdaq reported Q2 2026 non-GAAP EPS of $1.07, up 25% YoY and above the $0.98 Zacks consensus by 9.18%; net revenues rose 15% to $1.5B, beating estimates by 3.87%. Annualized recurring revenue grew 11% to $3.3B with 12% organic ARR growth, while non-GAAP operating margin expanded 200 bps to 57% on revenue outpacing a 10% expense increase. Nasdaq returned $174M in dividends and $356M via share repurchases and repaid $162M of debt, and it raised 2026 non-GAAP operating expense guidance to $2.530B–$2.570B from prior levels, citing higher compensation, marketing, and continued technology investment.

Analysis

This quarter strengthens the case that NDAQ should trade less like a cyclical exchange and more like a hybrid infrastructure/software asset. The key mechanism is mix: recurring SaaS and fintech now matter enough that incremental revenue should convert at higher marginal EBITDA than the market gives credit for, supporting a valuation gap versus more transaction-dependent peers. If investors believe the growth mix is durable, the stock can rerate toward the higher-quality end of the market infrastructure group rather than screen as a low-growth exchange complex.

The second-order read-through is favorable for the broader exchange/data stack but uneven across competitors. NDAQ’s momentum in listings, index products, and compliance tech is a warning sign for slower-growth platform names that still rely on trading volumes alone; it also raises the bar for CBOE and CME to prove their own growth is not just a rate/volatility artifact. The main near-term risk is that the current strength is partly self-reinforcing from buoyant capital markets, so any cooling in IPO cadence, ETF inflows, or market volatility could hit the highest-multiple part of the story first, while the expense step-up limits immediate margin upside.

Consensus may be underestimating how much of this is a structural mix shift rather than a one-quarter beat. That said, the market may also be overpaying for the AI/tokenization narrative before revenue contribution is visible; those initiatives are optionality, not earnings. What would falsify the bull case over the next 1-3 months is any sign that recurring ARR growth decelerates back toward high-single digits or that management’s higher spend fails to preserve 55%+ operating margins; over 6-18 months, a weaker listings and index AUM backdrop would force a de-rating.

Key Decisions for Investors

• Long NDAQ on pullbacks over the next 1-3 sessions; use the thesis that recurring mix and margin quality justify a relative multiple re-rating versus CME/CBOE. Risk/reward is attractive if the market keeps rewarding software-like financial infrastructure, but trim if the stock fails to hold post-earnings gains for 2-3 days.
• Pair trade: long NDAQ / short CBOE for 1-3 months. The mechanism is that NDAQ has more visible recurring revenue and broader productization, while CBOE remains more exposed to volatility normalization. Falsifier: a sharp pickup in VIX/volumes that reaccelerates CBOE faster than NDAQ.
• Watchlist alert on NDAQ if it revisits the pre-earnings breakout area after any market selloff; that would be the preferred entry for a medium-term long. Target is multiple expansion if investors start valuing the SaaS/fintech mix at closer to market-software peers.
• Avoid chasing CME/ICE on this print; relative upside is smaller because their growth is more tied to trading volume or mature data franchises. If you need an expression on the sector, prefer NDAQ as the cleaner quality-growth beneficiary.